We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Oregon Health and Science University Microarray Core Facility Licenses Metacore from Genego

Listen with
Speechify
0:00
Register for free to listen to this article
Thank you. Listen to this article using the player above.

Want to listen to this article for FREE?

Complete the form below to unlock access to ALL audio articles.

Read time: Less than a minute

GeneGo, Inc. has announced that OHSU Affymetrix microarray core facility licensed a portfolio of its data analysis products. OHSU scientists will use MetaCore for pathway analysis; MetaDrug for chemogenomics, MapEditor for pathway editing and communication and MetaLink for adding their own interactions to MetaCore’s manually curated pathways.

The Affymetrix Microarray Core (AMC) facility provides RNA Expression Profiling and DNA Variation Analysis services using Affymetrix GeneChip® oligonucleotide arrays. DNA Variation services include genome wide SNP genotyping, copy number and LOH detection.

“We are very pleased to have the OHSU core microarray center as a GeneGo customer,” said Julie Bryant, Vice President of Business Development for GeneGo.

“OMICs core labs are our primary customers, as they provide both assays and analysis to the research communities at the universities. By having access to all of our tools OHSU will have a comprehensive platform for analyzing pathways, adding proprietary data through editing capabilities and easy sharing with colleagues by just right clicking on experiments or analyses.”